These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 994538)

  • 21. The effect of sodium salicylate and epinephrine on the release of lactate dehydrogenase from isolated rat heart.
    Tutterová M; Mosinger B; Vavrínková H
    Acta Biol Med Ger; 1980; 39(4):433-43. PubMed ID: 7445893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischemic damage and metabolism during elective cardiac arrest.
    Hearse DJ; Stewart DA
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():277-89. PubMed ID: 1208980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1987 Mar; 93(3):415-27. PubMed ID: 3821150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why are newborn hearts vulnerable to global ischemia? The lactate hypothesis.
    Chiu RC; Bindon W
    Circulation; 1987 Nov; 76(5 Pt 2):V146-9. PubMed ID: 3665012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of multidose coronary artery washout during elective cardiac arrest and cardiopulmonary bypass: biochemical and hemodynamic evaluation.
    Walls JT; Nasser FN; Baron DW; Tinker JH; Harrison CE
    J Thorac Cardiovasc Surg; 1982 May; 83(5):772-8. PubMed ID: 7078246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depressed postoperative cardiac performance. Prevention by adequate myocardial protection during cardiopulmonary bypass.
    Buckberg GD; Olinger GN; Mulder DG; Maloney JV
    J Thorac Cardiovasc Surg; 1975 Dec; 70(6):974-94. PubMed ID: 1186289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural study comparing the efficacy of five different methods of intraoperative myocardial protection in the human heart.
    Schaper J; Scheld HH; Schmidt U; Hehrlein F
    J Thorac Cardiovasc Surg; 1986 Jul; 92(1):47-55. PubMed ID: 3088335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart.
    Shlafer M; Kane PF; Kirsh MM
    J Thorac Cardiovasc Surg; 1982 Jun; 83(6):830-9. PubMed ID: 7087509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurologic outcome and heart resuscitability with closed-chest cardiopulmonary bypass after prolonged cardiac arrest times in rabbits.
    Xu X; Ogata H
    Crit Care Med; 1994 Dec; 22(12):1987-94. PubMed ID: 7988138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of crataegus extract on the cardiac mechanical dysfunction in isolated perfused working rat heart.
    Nasa Y; Hashizume H; Hoque AN; Abiko Y
    Arzneimittelforschung; 1993 Sep; 43(9):945-9. PubMed ID: 8240455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS; Hearse DJ
    Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection from ischemic cardiac arrest by coronary perfusion with cold Ringer's lactate solution.
    Tyers GF; Hughes HC; Todd GJ; Williams DR; Andrews EJ; Prophet GA; Waldhausen JA
    J Thorac Cardiovasc Surg; 1974 Mar; 67(3):411-8. PubMed ID: 4813443
    [No Abstract]   [Full Text] [Related]  

  • 34. Critical importance of ensuring cardioplegic delivery with coronary stenoses.
    Becker H; Vinten-Johansen J; Buckberg GD; Follette DM; Robertson JM
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):507-15. PubMed ID: 7206757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of reperfusion injury after ischemic arrest with pressure-controlled intermittent coronary sinus occlusion.
    Lazar HL; Rajaii A; Roberts AJ
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):637-42. PubMed ID: 3352298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac prostacyclin kinetics during cardiopulmonary bypass.
    Kobinia GS; LaRaia PJ; Peterson MB; D'Ambra MN; Watkins WD; Austen WG; Buckley MJ
    J Thorac Cardiovasc Surg; 1984 Dec; 88(6):965-71. PubMed ID: 6389992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protection of oxyphenamone against cardiac arrest-reperfusion injury of isolated rat hearts].
    Fan LL; Li H; Fan MJ; Zhang RD
    Yao Xue Xue Bao; 2005 Aug; 40(8):705-10. PubMed ID: 16268504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of the pediatric myocardium. Differential susceptibility to ischemic injury of the neonatal rat heart.
    Yano Y; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1987 Dec; 94(6):887-96. PubMed ID: 3682858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioplegia and slow calcium-channel blockers. Studies with verapamil.
    Yamamoto F; Manning AS; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):252-61. PubMed ID: 6876861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in electrical and mechanical recovery from ischemic heart arrest and cardioplegia.
    Juggi JS; Braveny P; Telahoun G; Shuhaiber HJ; Yousof AM
    Adv Myocardiol; 1985; 6():491-502. PubMed ID: 3992047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.